ArticleAnnals of the rheumatic diseases2023

Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'.

Aaqib Zaffar Banday et al.PubMed ↗Publisher ↗

No numbers read from the abstract.